Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02924038
Title A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nicholas Butowski
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field